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Available online 25 June 2013Weight management for individuals with intellectual and developmental disabilities (IDD) has
received limited attention. Studies on weight management in this population have been
conducted over short time frames, in small samples with inadequate statistical power,
infrequently used a randomized design, and have not evaluated the use of emerging effective
dietary strategies such as pre-packaged meals (PMs). Low energy/fat PMs may be useful in
individuals with IDD as they simplify meal planning, limit undesirable food choices, teach
appropriate portion sizes, are convenient and easy to prepare, and when combined with fruits
and vegetables provide a high volume, low energy dense meal. A randomized effectiveness
trial will be conducted in 150 overweight/obese adults with mild to moderate IDD, and their
study partners to compare weight loss (6 months) and weight maintenance (12 months)
between 2 weight management approaches: 1. A Stop Light Diet enhanced with reduced
energy/fat PMs (eSLD); and 2. A recommended care reduced energy/fat meal plan diet (RC). The
primary aim is to compare weight loss (0–6 months) and weight maintenance (7–18 months)
between the eSLD and RC diets. Secondarily, changes in chronic disease risk factors between the
eSLD and RCdiets including blood pressure, glucose, insulin, LDL-cholesterol, andHDL-cholesterol
will be compared during bothweight loss andweightmaintenance. Finally, potentialmediators of
weight loss including energy intake, physical activity, data recording, adherence to the diet, study
partner self-efficacy and daily stress related to dietary change will be explored.
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Intellectual and developmental disability
Weight management
Pre-packaged meals
Physical activity
Weight maintenance
Stop Light DietD, intellectual and developmental disabilities; PMs, pre-packaged meals; RC, recommended care.
e and Kidney Diseases (R01-DK83539).
kaged meals.
100, The University of Kansas-Lawrence, 1301 Sunnyside Avenue, Lawrence, KS 66045, USA. Tel.: +1 785
), rrsaun@ku.edu (R.R. Saunders), msaundrs@ku.edu (M. Saunders), rwashburn@ku.edu (R.A. Washburn),
u (C.A. Gibson), lptomey@kumc.edu (L.T. Ptomey), jgoetz@kumc.edu (J.R. Goetz), jhonas@ku.edu
du (M.R. Rondon), bryasmi@siue.edu (B.K. Smith), mmayo@kumc.edu (M.S. Mayo).
r Inc. Open access under CC BY-NC-ND license.
117J.E. Donnelly et al. / Contemporary Clinical Trials 36 (2013) 116–1241. Introduction
The rate of obesity among individuals with intellectual and
developmental disabilities (IDD) is higher than in the general
population [1–4] and higher in those living in the community
comparedwith those living in institutions. Community dwelling
individuals with IDD likely adopt physical activity [1,5,6] and
dietary characteristics [7–9] of the general population which
promote weight gain [10–12] and its associated co-morbidities
[6,13–23]. The severity of obesity in individuals with IDD has
been recognized [24]; however, the limited data for weight loss
in this group using energy reduced meal plans (~1.5 to 3% from
baseline) are discouraging and are considerably less than
National Heart Lung and Blood Institute guidelines (10%) [18]
and that observed in weight loss trials in the general population
[25]. Lack of success may be due in part to the difficulty of
teaching, administering and maintaining compliance with a
typical energy reduced meal plan diet among individuals with
IDD.
Preliminary to this study our group conducted a
12-month pilot weight loss trial to evaluate an alternative
dietary strategy in 73 individuals with mild to moderate
IDD (BMI = 37.0 ± 8.4, age = 31.6 ± 9.6 yrs., 56% female)
[26]. Approximately 30% o participants lived at home, while
others were in supported living consisting of 1–4 residents.
Energy restriction (500–700 kcal/day below requirements)
was achieved using an enhanced Stop Light Diet (eSLD). The
SLD, originally developed by Epstein [27] has been successful
for weight loss in children [27–29] and may be appropriate for
use among individuals with IDD. The SLD categorizes foods by
energy content: green (low energy: consume freely), yellow
(moderate energy: consume in moderation) and red (high
energy: consume sparingly). SLD was enhanced by encourag-
ing consumption of high volume, low energy, pre-packaged
meals (PMs: entrees/shakes) and 5 fruits/vegetables each day
to control portion size and reduce both energy and fat intake.
Results for the 66 participants who completed the study (10%
loss to follow-up) demonstrated weight loss of 6.4%, and 8.7%
from baseline at 6 and 12 months, respectively. These levels of
weight loss are similar to the results from the successful
Diabetes Prevention Program [25] and exceed the 3%minimum
weight loss suggested as clinically relevant in the American
College of Sports Medicine Position Stand “Appropriate physical
activity intervention strategies forweight loss and prevention of
weight regain for adults,” [31]. These encouraging results led to
the development of the current trial designed to compare both
weight loss and weight maintenance between the eSLD and a
recommended care (RC) meal plan diet in adults with IDD.
2. Methods and materials
2.1. Overview of study design
One hundred sixty overweight/obese adults with mild to
moderate IDD and their study partners will be randomized to
an 18 month effectiveness trial with 6 month weight loss and
12 monthweightmaintenance to compare two approaches for
weightmanagement [eSLD vs. RC] [32]. Following the 6-month
weight loss period, both groups will be encouraged to either
continue the weight-loss protocol with the eSLD or RC or to
continue at a level of energy intake designed to provideweightmaintenance. Both groups will be asked to wear a step counter
and record steps walked, with an eventual goal of 150 min per
week. The primary aim is to compareweight loss (months 0–6)
between the eSLD and RC diets. Secondary aim one is to
compare weight maintenance (months 7–18) between the
eSLD and RC diets. Secondary aim two is to compare changes in
chronic disease risk factors including blood pressure, glucose,
insulin, and LDL and HDL-cholesterol between the eSLD and RC
diets bothweight loss andweightmaintenance. Secondary aim
three is to explore potential mediators of weight loss including
energy balance variables (energy intake, physical activity),
process variables (self-monitoring, dietary and physical activ-
ity adherence) and psychosocial variables (study partner
self-efficacy and daily stress related to dietary change).
2.2. Participant eligibility
Caregivers play an important role in the lives of individuals
with IDD and provide assistance with food shopping and
meal planning and preparation. Therefore a caregiver for the
individual with IDD that is either a parent/guardian, a member
of the support staff who assists in their residence, or a person
who assists the individual with the purchase of food will be
recruited with each participant. We refer to this person as the
participant's “study partner.” The study partner agrees to
participate in each of our meetings with the participant, and to
support the participant in following the diet. To enhance the
generalizability of our results individuals who use medications
for elevated health risks commonly associatedwith overweight
and obesity, such as elevated blood pressure or lipids are
not excluded as these conditions are prevalent in individuals
with IDD and are likely to be improved with weight loss
and increased physical activity. Likewise, individuals who are
taking medications that may induce weight gain or inhibit
weight loss are not excluded as these medications are
frequently prescribed for individuals with IDD. Randomization
should ensure that medication use is equally distributed across
the 2 study groups. Specific participant eligibility criteria are
presented in Table 1.
2.3. Recruitment procedures/randomization
An information brochure that describes the project will be
mailed/emailed to case managers, service providers and
Community Developmental Disability Organizations in the
recruitment area. Upon request, meetings with these groups,
including potential participants, will be scheduled to allow
project staff to present details regarding the project and
answer questions. Potential participants will be contacted by
a member of the investigative team who is familiar with the
sensitive issues regarding recruitment of individuals with IDD.
Home-visits will be scheduled to verify eligibility and answer
any remaining questions. Written informed consent will be
obtained from either the participant (self as guardian) or their
legal guardian and their study partner. Randomization, strati-
fied by gender and by living arrangement (i.e., number of
participants in a residence) to assure balanced allocations, will
be completed after written consent and written physician
clearance are obtained. Treatment allocation sequences will be
generated by computer software using block randomization
with equal allocation to the eSLD and RC groups.
Table 1
Participant eligibility criteria for an 18-month weight loss and maintenance intervention in adults with intellectual and developmental disabilities.
Inclusion
Residential status: Live with parents or in supported living in North East Kansas (≤50 miles from Lawrence, KS) with a
maximum of 4 other individuals with IDD.
Age: ≥18 years
Diagnosis: Mild to moderate IDD as determined by a Community Service Provider operating in Kansas under the
auspices of a Community Developmental Disability Organization (CDDO).
Overweight/obese: BMI N 25 kg/m2
Ambulatory: Must be able to walk.
Health status: Must provide physician clearance to participate.
Communication: Potential participants must be able to communicate preferences (e.g., foods liked and disliked),
wants (e.g., more to eat, drink), and needs (e.g., assistance with food preparation) through
spoken language, sign language, or augmentative and alternative communication systems, such as voice
output communication aides.
Ability to consent: Potential participants will be judged competent to give informed consent by their CDDO or will
have a guardian with power of attorney. If a guardian indicates consent but the individual with IDD does
not want to participate, the individual will not be enrolled
Exclusion
Health concerns: Individuals with uncontrolled hypertension, severe heart disease, cancer, HIV, etc. Individuals
with diabetes will be receiving a special diet per state regulatory statute and thus are not eligible.
Individuals who are currently being treated for depression or eating disorders.
Recent weight loss: Participation in a weight loss program within the past 6 months.
Pregnancy: Individuals who become pregnant during the study will be dropped and referred for appropriate services.
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2.4.1. Enhanced Stop Light Diet (eSLD)
The original Stop Light Diet (SLD), developed by Epstein
[27], is an effective weight loss strategy for children [27–29] as
indicated by a Grade 1 ranking (strong, consistent, supporting
evidence) from The Academy of Nutrition and Dietetics
Evidence Analysis Library [30]. The SLD categorizes foods by
energy content: green (low energy: consume freely), yellow
(moderate energy: consume in moderation) and red (high
energy: consume sparingly). This approach is easy for children
and individuals with IDD and their caregivers to understand
and adopt. In this study, lists and/or pictures of foods will be
provided and are color-coded to the stoplight system for use in
meal planning, shopping and snacking. As in the pilot, the SLD
will be enhanced (i.e., eSLD) by encouraging consumption of
high volume, low energy, pre-packaged meals (PMs: entrees/
shakes) with at least 5 fruits/vegetables each day. PMs are
effective to control portion size and reduce both energy/fat
intake. Participants using eSLD will be taught to shop for
entrees with approximately 300 kcal or less. The use of PMs
consistently demonstrates significantly greater weight loss
when compared with conventional reduced energy diets
[33–36]. The Academy of Nutrition and Dietetics Evidence
Analysis Library indicates Grade I support for the use of PMs in
individuals who have difficulty with self-selection of food and
portion control [30]. PMs simplify meal planning, food shopping
and meal preparation for both individuals with IDD and their
caregivers. This may be especially important considering that
caregivers frequently have limited formal education, not specific
to nutrition, and the rate of turnover among paid caregivers is
high [37]. Participants wanting food outside of the PMs plus 5
servings of fruits and vegetables, will be encouraged to use
the SLD color-coded food lists to select additional servings of
reduced-energy foods. Low-energy, high-volume shakes, which
can be consumed as snacks or as a drink with a meal, will be
provided by the project (two per day) during the 6-month initial
weight-loss phase. The shakes are available in chocolate andvanilla flavors and can be mixed with fruits, diet sodas, flavor
extracts, and other low energy items to expand flavor variety.
Participants randomized to either the eSLD or recommended
care diets who achieve a BMI of 22 kg/m2 any time during the
weight loss phase will be transitioned to the maintenance level
of energy intake.
2.4.2. Recommended care (RC) diet
RC will be a conventional reduced energy, meal plan diet as
recommended by the United States Department of Agriculture,
Center for Nutrition Policy and Promotion dietary guidelines
[38]. Energy intake duringweight losswill be reduced to 500 to
700 kcal below daily resting energy expenditure as estimated
using the equation of Mifflin-St Jeor [39] multiplied by 1.4 to
1.6 to account for physical activity. It is recognized that this, or
any equation for estimating daily energy expenditure, was not
developed for use in individuals with IDD and that body
composition and energy metabolism among individuals with
IDD may differ from those in the general population. However,
this estimate should provide a reasonable starting point
for prescribing a reduced energy diet. Further adjustments
in energy intakewill bemade in response toweight loss or gain
by increasing or decreasing the targeted energy intake.
Participants and their study partners will work together to
prepare the proper foods in portions appropriate for each
participant's energy requirements. Compliance with a conven-
tional meal plan diet requires selecting, purchasing, and
preparing appropriate foods from an unlimited array of
options, as well as serving a portion size for the appropriate
reduction of energy intake.
2.4.3. Energy intake during weight maintenance (months 7 to 12)
During the weight maintenance phase participants will be
able to choose if they want to continue to lose weight or work
to maintain their weight. Although a participant may choose
to continue to lose weight they will no longer be provided
PMs (eSLD), fruit/vegetable money (RC), or receive incen-
tives for losing weight. Energy intake for weight maintenance
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equation of Mifflin-St Jeor [39] multiplied by 1.6 to 1.8 to
account for physical activity. If weight gain is documented
during monthly home visits by study staff (Section 2.6.4)
suggestions will be provided to improve compliance to the
prescribed level of energy intake for weight maintenance.
2.4.4. Volumetrics
Both eSLD and RC diets will employ the “volumetrics”
concept (i.e., choosing foods high in volume and low in
energy) which has been shown to improve weight loss and
weight maintenance [40]. Well-controlled, lab-based studies
have repeatedly demonstrated that the weight or volume of
food, rather than energy content, determines the degree of
satiety, and that individuals tend to eat the same volume of food
over time regardless of its energy content [41,42]. Volumetric
strategies to reduce energy intake include increasing water
content of meals, either through consumption of water-rich
fruits and vegetables or the incorporation of soups, addingmore
fiber through fruits and vegetables, and fiber-rich grains, and
reducing fat content by using low-fat, low-calorie substitutions
(e.g., using skim milk instead of whole milk) and using low-fat
cooking techniques [43]. For example, the volume of a RC meal
of low-fat pasta salad and yogurt could be increased, and energy
density decreased by adding vegetables to the salad and fruit to
the yogurt. The same strategy can be applied to the eSLD using a
single serving PMentreemixedwith additional vegetables and a
high volume shake blended with fruit for a smoothie.
2.5. Intervention components: Physical activity
Participants will be encouraged to accumulate at least
30 min per day of moderate intensity physical activity at least
5 days per week with a target of 150 min per week. We are
aware that some agencies recommend greater levels of
physical activity for weight loss and especially for weight
maintenance [31,44]. These guidelines were written for the
general population; however, our experience from the pilot
indicates 150 min per week is a reasonable target for in-
dividuals with IDD. To achieve this goal, participants will walk
with a step counter and gradually accumulate ~30 min of
walking a day. Walking as a recommended mode of physical
activity has several advantages. First, it fits easily into the daily
routine and work day of most individuals. Second, walking
ranks as the top preference for physical activity among
individuals with IDD, most likely because it can be done in
any amount or intensity, and can be used as a form of
transportation [5]. Third, walking can be performed alone or
with others if a social component is desired. Fourth, the
intensity of walking is relatively easy to control compared to
games or sports. Fifth, walking is very safe form of activity with
the potential for injury generally limited to soreness or mild
strains, sprains, etc. Intermittent activity will be encouraged as
it fits well into the work day (i.e. work breaks, lunch time etc.),
allows de-conditioned participants to accumulate a greater
volume of activity sooner compared to a continuous activity
program, andmay diminish the perception of fatigue due to the
shorter activity time and the rest that occurs between activity
bouts. Therefore, intermittent physical activity may be espe-
ciallywell suited for the initiation of a physical activity program
for sedentary individuals with IDD.2.6. Intervention implementation
2.6.1. Participant and study partner training
Both participants and study partners will be trained to
implement the intervention and to comply with the study
requirements for data reporting. Training will be conducted by
study staff during a 60–90 minute home visit conducted at
baseline and at a 30-minute home visit at about two weeks
after initiating the diet. The frequency and duration of research
staff and participant/study partner contact are equal for the
eSLD and RC groups across the 18-month study. Training
for both the eSLD and RC groups will include information
regarding meal planning (energy levels/fat content/portion
size), as well as food shopping and meal preparation. The eSLD
group will be introduced to the food color categorization
approach of the SLD through a chart provided at baseline
training. Participants and study partners will be trained to use
the color coded chart to aid inmeal planning, grocery shopping,
decisions regarding snack foods, and compliance with the diet
while traveling and eating away from home (i.e., restaurants,
parties etc.). The chart provides a neutral “third party” to
facilitate discussions between participants and study partners.
For example, the study partner may avoid confronting a
participant who makes an inappropriate snack choice with
words such as “you shouldn't eat that,” by instead pointing to
healthy snack food items on the chart as a better alternative.
Participants and study partners in both diet groups will
be taught problem solving/relapse prevention strategies for
complying with the diets and the physical activity component
of the intervention. Participants and study partners will be
instructed how the step counters should be worn (at hip), the
counts recorded and the counters reset. Participants and study
partners will be instructed to record steps walked and minutes
of alternative physical activities on a data sheet provided by
project staff. Participant and study partner training will
be conducted by study staff when the diet assignment is
revealed (60–90 min), during a 30 min session at about two
weeks after the individual initiates participation, and again as
needed during regularmonthly homevisits (Section 2.6.2). The
frequency and duration of research staff and participant/study
partner contact are equal for the eSLD and RC groups across the
18 month study.
2.6.2. Weekly tracking of compliance data
Participants, with assistance from their study partners, will
be asked to complete data recording cards that are specific to
their study group (eSLD/RC) across the 18 month study. Based
on our pilot study it is anticipated that data recording and
reporting will require approximately 5 min per day to complete
[26]. Daily data regarding the use of meal plans, the number of
PMs (entrees/shakes), fruits, and vegetables consumed and
physical activity (pedometer steps: pedometer provided/
minutes) recorded by participants and their study partner and
weekly totals will be summarized by study staff. Furthermore,
any reactive behavior or adverse events will be recorded by
study partners and passed onto study staff at home visits. Data
cards will be picked up by study staff during monthly ~1 hour
home visits conducted across the 18 month study. Monthly
home visits are designed to answer questions and problem
solving regarding compliancewith the intervention and to assess
body weight to provide feedback to participants regarding their
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assessed with participants wearing a t-shirt, shorts, and no
shoes. Data from the weekly tracking sheets will be used for
process evaluation, to determine qualification for incentives
and to identify areas to be addressed by study staff during
subsequent monthly meetings.2.6.3. Participant incentive
Individuals with IDD are often more able to meet their
own expectations, as well as the expectations of others, when
participating in a formal incentive system, often referred to
as contingency management systems or positive behavior
support programs. Participants in these programs earn a
modest incentive in the form of cash, special activities or
special privileges etc., for completing specific behaviors. The
modest incentive provides motivation to meet the goal and
receive reinforcement, but is not large enough to be coercive.
To improve compliance with the study in the first 6 months,
participants with assistance from their study partners, will be
asked to record daily consumption of their prescribed meal
plan on a pictorial recording form specific to either the eSLD
or RC diets. During each monthly meeting study staff will
review the records and provide a small monetary incentive
(≤$16.00/month) for recording consumption of foods/beverages
consistent with the study diets. Furthermore, monetary in-
centives ($10.00) will be provided when a participant's BMI is
reduced by 1 unit and ($5.00) will be provided for each 100,000
steps recorded. During the weight maintenance period (months
7–18), participants will no longer be paid for recording foods
eaten, loss of a BMI point, or stepswalked. A flat fee ($20)will be
paid for attending each monthly meeting. Participants will have
the potential to receive a maximum of ~$560 in incentives over
the 18 month intervention.2.6.4. Behavioral reactivity
Participants with IDD may display behavioral reactivity to
either the dietary or physical activity components of the
intervention ranging from insistence that a study partner
provide a high calorie snack to refusal to engage physical
activity. The incentive programs will be our primary means
of preventing reactive behavior; nevertheless, it may occur.
If reactive behavior is indicated onweekly reports or inmonthly
meetings, co-investigators (RS, MS) will offer suggestions for
minimizing the problem in the future, such as agreeing on a new
approach to negotiating food choices or changes in approaches
to shopping or food preparation. Reactive behaviorwill be noted
in monthly meeting notes.2.6.5. Medical management
Physician clearance via a consent formwill be required for
participation in this trial. To facilitate medical management,
study staff will alert the participant's personal physician, who is
responsible for any adjustments in medication necessitated by
change in weight (~10%) resulting from participation in this
trial. We chose this approach rather than using a dedicated
study physician as this system represents howmedial manage-
ment would be conducted outside the constraints of a research
trial.2.7. Outcome assessments
Major outcomes including anthropometrics (weight/height/
BMI/waist circumference), blood pressure, blood chemistry and
physical activity (accelerometer) will be assessed at baseline,
following weight loss (month 6) and at months 12 and 18
during weight maintenance. Blood chemistry will only be
assessed if consent is granted by the participant. All outcomes
(including blood samples) will be assessed at the participant's
home during a single visit by study staff blinded to condition;
the same protocol we used successfully in the pilot [26]. Based
on the pilot study we estimate that these assessments will
require approximately 75 min to complete with the exception
of accelerometry that will be assessed across 7 days. A schedule
for all assessments is presented in Table 2.
2.7.1. Anthropometrics (weight/height/waist circumference/BMI)
Participants will be weighed in a hospital gown between 8
and 10 AM, in duplicate, on a calibrated scale (Model
#PS6600, Belfour, Saukville, WI) to the nearest 0.25 kg,
following an overnight fast (~12 h). Standing height will be
measured in duplicate with a portable stadiometer (Model
#IP0955, Invicta Plastics Limited, Leicester, UK). BMI will be
calculated as weight (kg)/height (m2). Waist circumference,
as a surrogate for abdominal adiposity, will be assessed using
the procedures described by Lohman et al. [45]. Three
measurements will be taken with the outcome recorded as
the average of the closest 2 measures.
2.7.2. Blood pressure/blood chemistry
Blood pressure will be measured using a Dinamap automat-
ed sphygmomanometer (Pro Care 100, GEHealthCare,Madison,
WI) between 8 and 10 AM, subsequent to the assessment of
height, weight, and waist circumference. The participant will be
seated with the arm bared, supported, and positioned at the
heart level. Measurement will begin following 5 min of quiet
rest. The appropriate size cuff will be used such that the rubber
bladder encircles at least 2/3 of the arm. Two measures will be
averaged and additional measures will be obtained if those
measures differ by more than 5 mm Hg [46,47]. Fasting blood
samples (12 h overnight fast) for the assessment of blood lipids,
glucose, and insulin will be obtained by a phlebotomist
experienced in working with individuals with IDD, subsequent
to the measurement of blood pressure. Blood samples will be
placed on ice and immediately transported to our laboratory
where plasma will be separated by centrifugation for 15 min at
2000 g. Plasma will be transferred to cryogenic vials and stored
at −70° C for later analysis. Total serum cholesterol and
triglyceride concentrations will be measured using an automat-
ed analyzer (Du Pont Co), using standard enzymatic techniques.
HDL will be measured after removal of VLDL and LDL by
precipitation with phosphotungstate [48]. Glucose will be
measured using an autoanalyzer (Beckman) and insulin will
be measured using a double-label antibody technique [49].
2.7.3. Energy and macronutrient intake
Energy and macronutrient intake is assessed by a 3-day
food record (2 weekdays, 1 weekend-day). Participants and
study partners are trained (Section 2.6.3) to complete the
records, and a trained staff member will review the records
with the participant and parents using portion guides and
Table 2
Assessment schedule.
Assessment Weekly Monthly Baseline 6 months 12 months 18 months
Anthropometricsa x x x x
Blood chemistry & blood pressure b x x x x
Physical activity (7-day accelerometer) x x x x
Dietary intake (3-day food record) x x x x
Overall program satisfaction & acceptability x x x
Study partner self-efficacy x x
Daily stress for dietary change x x
Dietary intake (24 h recalls) x
External or competing factors x
Body weight (for feedback/counseling) x
Self-monitoring data (diet, physical activity) x
Behavioral reactivity x
a Anthropometrics includes height, weight, waist circumference, and BMI.
b Blood chemistry includes lipids, insulin, and glucose.
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nutrient content of dietary information will be determined
using the current version of the Nutrition Data System for
Research (NDSR, University of Minnesota; Minneapolis, MN).
To assist with counseling on weight loss and maintenance
24-hour multi-pass dietary recalls will be obtained at each
monthly client/staff meeting.
2.7.4. Physical activity-accelerometer
Participants will wear an ActiGraph GT1X portable
accelerometer (ActiGraph LLC, Pensacola, FL) on a belt over
the non-dominant hip for 7 consecutive days (5 week days
and 2 week-end days) at each assessment time point.
Accelerometer data will be collected in 1-min epochs with a
minimum of 12 h constituting a valid monitored day.
Accelerometers will be distributed to the participant on
Wednesdays, worn Thursday–Wednesday and returned on
Thursdays using pre-addressed and stamped padded enve-
lopes. Study partners will be asked to assist in achieving
compliance with the monitoring protocol. The main outcome
variable will be the average ActiGraph counts/min over the
7-day period. In addition, the average number of min/day
over 7-days spent at various activity levels will be assessed
applying the cut-points used in the National Health and
Nutrition Examination Survey as described by Troiano et al.
[50].
2.8. Process evaluation
We will document and evaluate the program components
required to administer the intervention. This information will
be important for both future trials and the translation of our
intervention to agencies that provide support services for
individuals with IDD.
2.8.1. Implementation and reach
We will track the extent to which the intervention was
implemented and received by both participants and their
study partners. Following initial training, the degree to which
study partners feel adequately trained and confident to
perform intervention requirements (e.g., develop meal plans,
use PMs as part of eSLD, control portion size, assist with data
recording, encourage physical activity etc.) will be assessed
using a modified version of the study partner self-efficacy scaleoriginally developed by Heller et al. [51]. Study partnerswill be
asked to rate their level of confidence to perform each of the
intervention requirements on a 5-point scale (0 = not at all
confident to 5 = completely confident).
2.8.2. Fidelity
We will monitor the extent to which specific program
components were implemented as originally planned by
examining weekly self-monitoring logs (e.g., dietary intake
and physical activity).
2.8.3. External or competing factors
Potential threats to internal validity of the intervention,
such as a residence adopting a new weight loss or physical
activity program, change in residence or study partner, or any
changes in agency policies that may influence diet or physical
activity will be tracked by research staff during the monthly
home visits. At the same home visit, research staff will also track
changes in prescription medications such as anti-hypertensives,
psychotropics, diuretics etc., which might influence weight.
2.8.4. Program satisfaction and acceptability
Study partners will complete a 4-point Likert scale
(strongly agree to strongly disagree) at 6, 12 and 18 months
to assess the acceptability, ease/burden of administration,
and perceived usefulness of study staff for the intervention.
Focus groups will be conducted with study partners at the
end of the study. Focus groups will address whether the
program interfered with usual daily routines, level of burden
for meal planning and preparation, difficulty staying within
the prescribed calorie range, and the appropriateness of the
diet and physical activity intervention for individuals with
IDD. In addition, we will track the frequency of notations of
behavioral reactivity written in the monthly meeting notes.
2.9. Analysis plan and statistical power
Sample demographics and all outcome measures will be
summarized by descriptive statistics; means and standard
deviations for continuous variables and frequencies and
percentages for categorical variables. The primary analysis will
be based on the intention-to-treat principle. We will determine
if factors such as treatment group, baseline weight, age, gender
etc. are associated with the rate of missing data. Data that are
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regression and Generalized Estimated Equation Longitudinal
models. However, we will also use model based imputation, if
deemed necessary, to impute missing data longitudinally and
obtain model estimates and inference. Per protocol analysis
which will include only participants who complete ≥ 75% of
both weekly reports and outcome assessments will be
performed to compare between group differences in both
weight loss and weight maintenance. All statistical analysis
will be conducted using SAS versions 9.2 or higher with a type 1
error rate of 5%.
2.9.1. Analysis plan: weight loss
Two sample t-tests will be used to compare differences in
weight change (month 6 minus baseline weight) between
the eSLD and RC groups. Multiple linear regression will be
used to assess the impact of covariates including age, gender,
living arrangement, number of care givers, race, ethnicity,
baseline weight, energy and fat intake, physical activity etc.
while controlling for treatment group. We will also assess the
impact of the number of individuals with IDD residing in the
home on weight change. Although we will enroll only 1
individual with IDD per home, the number of residents per
home may impact the level of adherence, compliance, and
loss to follow-up in the trial. The residence per home variable
(range 1–4) will be treated as a covariate in all analysis.
2.9.2. Analysis plan: weight maintenance
A linear mixed model will be used to evaluate the weight
change over 12 months following weight loss (i.e., months
7–18). The group by time interaction will be tested controlling
for covariates including age, gender, and baseline weight. A
significant interaction would indicate group differences in
weight change following weight loss. A contrast will also be
performed to determine if there are significant between group
differences in weight change over months 7–18. Mixed linear
models will be used to assess the impact of covariates such as
age, gender, living arrangement, number of individuals living in
the home, race, ethnicity, physical activity, and energy/fat
intake, while controlling for treatment.
2.9.3. Analysis plan: chronic disease risk factors
Between group changes in chronic disease risk factors
including blood pressure, glucose, insulin, LDL and HLD
cholesterol will be assessed both during weight loss and weight
maintenance using the same analysis strategy described previ-
ously for body weight (Sections 2.9.1, 2.9.2).
2.9.4. Analysis plan: explore potential mediators of weight loss
Potential mediators for weight loss including energy balance
variables (energy intake, physical activity), process variables
(data recording, adherence), and psychosocial variables (study
partner self-efficacy) [51], and daily stress (related to dietary
change) [52] will be examined using the approach of Baron and
Kenny [53], and further extended by MacKinnon [54] and
Brown [55]. Mediation requires satisfaction of the following 4
criteria: 1) significant between group differences in outcome
(weight change); 2) significant between group difference for
potential mediators; 3) significant association between poten-
tial mediators and outcome; and 4) the association between
intervention group and the outcome (i.e., intervention effects)must be attenuated by the presence of the mediators in the
statisticalmodel. Analysis to satisfy criteria #1 and#2have been
previously described (Sections 2.9.1, 2.9.2). To evaluate criteria
#3, a sequence of independent linear mixed model equations
will be constructed. For each potential mediating variable, we
will determine if change in that variable is associated with
change in our primary endpoint (weight) using a linear mixed
model. For each of the potential mediators satisfying criteria #3,
we will proceed to criteria #4. We will create a linear mixed
model including the potential mediator and intervention group
with a change in weight. An attenuation of the association
between intervention group and outcome when potential
mediators are included in the model indicates some level of
mediation. These steps enable us to determine if full mediation
or partialmediation is present. If there are two ormore potential
mediators after primary mediation analysis a structural equa-
tion model will be constructed for the full or partial mediation.
If there is only one, then the original linear mixed model used
to determine if that variable is a potential mediator will be
used.
2.9.5. Analysis plan: process
Monitoring the extent and quality of implementation will
prevent “Type III error” in which an intervention that is not
fully implemented as planned, is not a true test of the
experimental hypotheses [56]. Descriptive statistics will be
used to provide a general description of the context in which
the interventions are conducted. All focus group session will
be moderated by a trained interviewer, audiotaped, and
transcribed. In addition, a recorder will take notes to ensure
that the transcriptions are accurate. Focus group data will be
coded and organized using ATLAS.ti (version 5.2) software.
The codes will be compared and discrepancies will be
resolved through discussion among the research staff. Coding
will facilitate content analysis of particular topics and the
identification of common themes.
2.9.6. Statistical power
Assuming an equal variance for the change in weight over
6 months in both intervention groups of 4.9 kg, 57 participants/
group will provide 80% power to detect a between group
difference of 2.6 kg using a two-sided two sample t-test with
alpha = 0.05. In the pilot, attrition was 10% at 6 months. In
order to account for greater attrition due to the longer length of
the proposed study and to be conservative, we will use an
attrition rate of 30%, so we will recruit 150 subjects in total to
assure the power of the study.
3. Discussion
Individuals with IDD are an underserved group with
higher levels of obesity and chronic disease risk than the
general population, and have received very little attention
for weight management. The limited number of studies
on weight management that have been completed in this
population have been conducted over short time frames, in
small samples with inadequate statistical power, infrequently
used a randomized design, and have not evaluated the use of
emerging effective dietary strategies such as PMs. In the
general population weight loss with interventions employing
PMs have been shown to be superior to conventional reduced
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management in individuals with IDD for those living at home
with parents and/or siblings or in supported living environ-
ments. Interviews with participants and study partners in the
pilot study indicated that convenience of meal planning and
preparation was a major consideration in complying with a
dietary recommendation. Individuals with IDD and their study
partners generally have limited knowledge and skill regarding
meal planning, preparation and portion control and are likely
to find planning, preparing and serving an appropriate portion
size of a conventional low energy/fat diet challenging com-
pared to the use of low energy/fat PMs and shakes, which
simply require heating or mixing. Low energy/low fat PMs
simplify meal planning, limit undesirable food choices, teach
appropriate portion sizes, are convenient and easy to prepare,
and when combined with fruits and vegetables provide a high
volume, low energy dense meal (i.e., volumetrics). The use of
PMs also allows for a variety of dietary choices as there are an
ever increasing number of reasonably priced, low energy/fat
PM products available at most grocery stores.
In this trial we will compare weight loss (0–6 months) and
weight maintenance (7–18 months) between a conventional
reduced energy/fat diet (RC) and a reduced energy/fat diet
delivered using an enhanced version of the Stop Light Diet
(eSLD). Both arms of this trial provide reduced energy/fat, high
volume/low energy density diets (i.e., volumetrics), emphasize
consumption of easily chewed fruits and vegetables, and
participation in physical activity. Thus, we will compare two
dietary strategies which both have a reasonable chance of
improving the health of the participants rather than using a
classic non-intervention control group for the following
reasons. First, we believe it is predictable that individuals
with IDD randomized to a non-intervention control group will
continue to exhibit increased levels of obesity and health risk as
there are no data in the IDD literature to suggest otherwise.
Second, we were concerned with the ethics of using a
non-intervention control in a group of overweight/obese
individuals with IDD, an under-served and vulnerable group,
who are clearly in need of effective strategies for weight
management. Third, a reduced energy/fat diet combined with
physical activity is considered to be “recommended care,” for
weight loss [31]. We expect clinically significant and greater
weight loss and less weight regain in the eSLD compared to
the RC group. However, the RC intervention may result in
weight loss of a magnitude sufficient to improve chronic
disease risk. If so, RC may be considered as an approach for
weight management in individuals with IDD.
The interventions in this trial will be delivered within the
existing system that is responsible for the health and
well-being of individuals with IDD. Individuals with IDD are
assisted in their weight management efforts by parents/and or
siblings with whom they live or by study partners. Therefore, if
successful it would be possible to scale and deliver the
intervention through the existing organizational and adminis-
trative structure to provide services for individuals with IDD.References
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